Eye Patch Therapy for Central Serous Retinopathy (CSR)



Status:Recruiting
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:7/11/2015
Start Date:November 2012
Contact:Sam Pistorius, COA CCRP
Email:pistoriuss@vision.wustl.edu
Phone:314-747-5832

Use our guide to learn which trials are right for you!

Eye Patching as a Potential Treatment Modality for and a Possible Etiological Insight on Central Serous Retinopathy

First, this study will investigate the viability of 24-hour eye patching as a potential
treatment modality for CSR. Second, this study will assess a potential physiologic
explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will
aid in ameliorating disease severity and disease duration.


Inclusion Criteria:

- Adults 18 years of age and older

- Both males and females

- Patients diagnosed with active central serous retinopathy

- Patients who are willing to use an eye patch in the affected eye for 24 hours

- Patients who are able to make the follow up appointments as required by the study

Exclusion Criteria:

- Individuals under 18 years of age

- Patients with vision less than 20/40 in the unaffected eye.

- Patients who are not able to undergo mfERG testing in a realiable manner.
We found this trial at
1
site
St Louis, Missouri 63110
?
mi
from
St Louis, MO
Click here to add this to my saved trials